These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 66208)

  • 1. Comparative studies on EBV antigens by immunofluorescence and immunoperoxidase techniques.
    Stephens R; Traul K; Gaudreau P; Yeh J; Fisher L; Mayyasi SA
    Int J Cancer; 1977 Mar; 19(3):305-16. PubMed ID: 66208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of Epstein-Barr virus antigens and antibodies by peroxidase-labeled specific immunoglobulins.
    Kurstak E; de Thé G; van den Hurk J; Charpentier G; Kurstak C; Tijssen P; Morisset R
    J Med Virol; 1978; 2(3):189-200. PubMed ID: 212523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma.
    Henle G; Henle W
    Int J Cancer; 1976 Jan; 17(1):1-7. PubMed ID: 175020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus-induced membrane antigens: immunochemical characterization of Triton X-100 solubilized viral membrane antigens from EBV-superinfected Raji cells.
    Qualtiere LF; Pearson GR
    Int J Cancer; 1979 Jun; 23(6):808-17. PubMed ID: 89099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of Epstein-Barr virus antigens with enzyme-conjugated antibody.
    Granlund DJ; Andrese AP
    Int J Cancer; 1977 Oct; 20(4):495-9. PubMed ID: 72045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A sensitive enzyme-linked immunosorbent assay (ELISA) against the major EBV-associated antigens. I. Correlation between ELISA and immunofluorescence titers using purified antigens.
    Luka J; Chase RC; Pearson GR
    J Immunol Methods; 1984 Feb; 67(1):145-56. PubMed ID: 6321599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutralizing EBV-specific IgA in throat washings of nasopharyngeal carcinoma (NPC) patients.
    Desgranges C; De-Thé G; Ho JH; Ellouz R
    Int J Cancer; 1977 May; 19(5):627-33. PubMed ID: 193801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation between Epstein-Barr viral and cell membrane immunofluorescence in Burkitt tumor cells. IV. Differentiation between antibodies responsible for membrane and viral immunofluorescence.
    Pearson G; Klein G; Henle G; Henle W; Clifford P
    J Exp Med; 1969 Apr; 129(4):707-18. PubMed ID: 4886045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An immunoprecipitation blocking assay for the analysis of EBV induced antigens.
    Bayliss GJ; Deby G; Wolf H
    J Virol Methods; 1983 Oct; 7(4):229-39. PubMed ID: 6317709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation between early and late membrane antigen on human lymphoblastoid cell lines infected with Epstein-Barr virus. I. Immunofluorescence.
    Ernberg I; Klein G; Kourilsky FM; Silvestre D
    J Natl Cancer Inst; 1974 Jul; 53(1):61-5. PubMed ID: 4365906
    [No Abstract]   [Full Text] [Related]  

  • 11. [Demonstration of IgG- and IgA-antibodies against Epstein-Barr virus-associated antigens with a microtiter enzyme immunoassay system. The determination of serum antibodies against the viral capsid antigen and the early antigen complex in the sera of tumor and infectious mononucleosis patients].
    Dölken G; Bitzer M; Bross KJ; Brugger W; Boldt C; Hirsch FW; Weitzmann U; Löhr GW
    Dtsch Med Wochenschr; 1984 Nov; 109(48):1837-43. PubMed ID: 6094138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient induction of a nuclear antigen unrelated to Epstein-Barr nuclear antigen in cells of two human B-lymphoma lines converted by Epstein-Barr virus.
    Fresen KO; zur Hausen H
    Proc Natl Acad Sci U S A; 1977 Jan; 74(1):363-6. PubMed ID: 189313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of Epstein-Barr virus (EBV) in various human disorders.
    Hewetson JF
    South Med J; 1975 Oct; 68(10):1271-3. PubMed ID: 170689
    [No Abstract]   [Full Text] [Related]  

  • 14. Early and late components of Epstein-Barr virus-associated membrane antigen in superinfected Daudi cells and their reactivity with sera from nasopharyngeal carcinoma patients.
    Hinuma Y; Sairenji T; Maeda M
    IARC Sci Publ (1971); 1978; (20):385-90. PubMed ID: 215521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic antibodies to cultured lymphoblasts unrelated to Epstein-Barr virus.
    Yang CS; Hewetson JF
    Int J Cancer; 1974 Oct; 14(4):530-8. PubMed ID: 4376526
    [No Abstract]   [Full Text] [Related]  

  • 16. Epstein-Barr virus-related serology in Hodgkin's disease.
    Henle W; Henle G
    Natl Cancer Inst Monogr; 1973 May; 36():79-84. PubMed ID: 4355353
    [No Abstract]   [Full Text] [Related]  

  • 17. Relation between Epstein-Barr viral and cell membrane immunofluorescence in Burkitt tumor cells. 3. Comparison of blocking of direct membrane immunofluorescence and anti-EBV reactivities of different sera.
    Klein G; Pearson G; Henle G; Henle W; Goldstein G; Clifford P
    J Exp Med; 1969 Apr; 129(4):697-705. PubMed ID: 4886044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of an Epstein-Barr virus early antigen and cell fusion].
    Furukawa M; Kamide M; Kato C; Sakashita H; Takeshita H; Umeda R
    Nihon Jibiinkoka Gakkai Kaiho; 1989 May; 92(5):722-5. PubMed ID: 2559176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-dependent lymphocyte cytotoxicity against cells expressing Epstein-Barr virus antigens.
    Pearson GR; Orr TW
    J Natl Cancer Inst; 1976 Mar; 56(3):485-8. PubMed ID: 176393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody response against the Epstein-Barr virus-coded nuclear antigen2 (EBNA2) in different groups of individuals.
    Seigneurin JM; Lavoue MF; Genoulaz O; Bornkamm GW; Lenoir GM
    Int J Cancer; 1987 Sep; 40(3):349-53. PubMed ID: 3040599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.